Table of Content



1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global RNAi Therapeutics Market - By Molecule Type
1.3.2 Global RNAi Therapeutics Market - By Application
1.3.3 Global RNAi Therapeutics Market - By Route of Administration
1.3.4 Global RNAi Therapeutics Market - By End User
1.3.5 Global RNAi Therapeutics market - By Geography

2. RNAi Therapeutics Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global RNAi Therapeutics Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa (MEA) - PEST Analysis
4.2.5 South and Central America (SCAM) - PEST Analysis
4.3 Expert Opinions

5. RNAi Therapeutics Market- Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Investments in RNAi Therapies
5.1.2 Rising Prevalence of Chronic Conditions and Infectious Diseases
5.2 Market Restraints
5.2.1 High Cost for RNAi Therapy Development
5.3 Market Opportunities
5.3.1 Significant Number of Pipeline Candidates for Strategic Alliances
5.4 Future Trends
5.4.1 Rising Emphasis on RNA Technologies
5.5 Impact analysis

6. RNAi Therapeutics Market - Global Analysis
6.1 Global RNAi Therapeutics Market Revenue Forecast and Analysis
6.2 Global RNAi Therapeutics Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players

7. RNAi Therapeutics Market- Molecule Type
7.1 Overview
7.2 RNAi Therapeutics Market Share, Molecule Type, 2019 and 2027 (%)
7.3 Small Interfering RNAs (siRNA)
7.3.1 Overview
7.3.1.1 Small Interfering RNAs (siRNA): RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
7.4 MicroRNA (miRNA)
7.4.1 Overview
7.4.1.1 MicroRNA (miRNA) Market: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)

8. RNAi Therapeutics Market- Application
8.1 Overview
8.2 RNAi Therapeutics Market Share, Application, 2019 and 2027 (%)
8.3 Genetic Disorders
8.3.1 Overview
8.3.1.1 Genetic Disorders: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
8.4 Oncology
8.4.1 Overview
8.4.1.1 Oncology: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
8.5 Neurodegenerative Disorders
8.5.1 Overview
8.5.1.1 Neurodegenerative Disorders: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
8.6 Cardiovascular Disorders
8.6.1 Overview
8.6.1.1 Cardiovascular Disorders: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
8.7 Respiratory Disorders
8.7.1 Overview
8.7.1.1 Respiratory Disorders: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
8.8 Infectious Diseases
8.8.1 Overview
8.8.1.1 Infectious Disease: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
8.9 Renal Diseases
8.9.1 Overview
8.9.1.1 Renal Diseases: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
8.10 Other Disorders
8.10.1 Overview
8.10.1.1 Other Disorders: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)

9. RNAi Therapeutics Market Market- Route of Administration
9.1 Overview
9.2 RNAi Therapeutics Market Share, Route of Administration, 2019 and 2027 (%)
9.3 Intradermal Injections
9.3.1 Overview
9.3.1.1 Intradermal Injections: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
9.4 Pulmonary Delivery
9.4.1 Overview
9.4.1.1 Pulmonary Delivery: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
9.5 Intravenous Injections
9.5.1 Overview
9.5.1.1 Intravenous Injections: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
9.6 Intraperitoneal Injections
9.6.1 Overview
9.6.1.1 Intraperitoneal Injections: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
9.7 Other Route of Administrations
9.7.1 Overview
9.7.1.1 Others: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)

10. RNAi Therapeutics Market Market- End User
10.1 Overview
10.2 RNAi Therapeutics Market Share, End User, 2019 and 2027 (%)
10.3 Diagnostic Laboratories
10.3.1 Overview
10.3.1.1 Diagnostic Laboratories: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
10.4 Research and Academic Laboratories
10.4.1 Overview
10.4.1.1 Research and Academic Laboratories: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
10.5 Hospitals
10.5.1 Overview
10.5.1.1 Hospitals: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)

11. RNAi Therapeutics Market - Geographic Analysis
11.1 North America: RNAi Therapeutics Market
11.1.1 Overview
11.1.2 North America: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.3 North America: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
11.1.4 North America: RNAi Therapeutics Market, by Application, 2018-2027 (USD Million)
11.1.5 North America: RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.1.6 North America: RNAi Therapeutics Market, by End User, 2018-2027 (USD Million)
11.1.7 North America: RNAi Therapeutics Market, by Country, 2019 & 2027 (%)
11.1.8 US: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.8.1 US: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.8.2 US: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
11.1.8.3 US: RNAi Therapeutics Market, by Application, 2018-2027 (USD Million)
11.1.8.4 US: RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.1.8.5 US: RNAi Therapeutics Market, by End User, 2018-2027 (USD Million)
11.1.9 Canada: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.9.1 Canada: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.9.2 Canada: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
11.1.9.3 Canada RNAi Therapeutics Market, by Application, 2018-2027 (USD Million)
11.1.9.4 Canada: RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.1.9.5 Canada: RNAi Therapeutics Market, by End User, 2018-2027 (USD Million)
11.1.10 Mexico: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.10.1 Mexico: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.10.2 Mexico: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
11.1.10.3 Mexico: RNAi Therapeutics Market, by Application, 2018-2027 (USD Million)
11.1.10.4 Mexico: RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.1.10.5 Mexico: RNAi Therapeutics Market, by End User, 2018-2027 (USD Million)
11.2 Europe: RNAi Therapeutics Market
11.2.1 Overview
11.2.2 Europe: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.2.3 Europe RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
11.2.4 Europe RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.2.5 Europe RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.2.6 Europe RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
11.2.7 Europe: RNAi Therapeutics Market, by Country, 2019 & 2027 (%)
11.2.8 Germany: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.2.8.1 Germany: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.2.8.2 Germany RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
11.2.8.3 Germany RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.2.8.4 Germany RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.2.8.5 Germany RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
11.2.9 UK: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.2.9.1 UK: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.2.9.2 UK RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
11.2.9.3 UK RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.2.9.4 UK RNAi Therapeutics Market, by Route of Administration- Revenue and Forecast to 2027 (USD Million)
11.2.9.5 UK: RNAi Therapeutics Market, End User - Revenue and Forecast to 2027 (USD Million)
11.2.10 France: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.2.10.1 France: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.2.10.2 France RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
11.2.10.3 France RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.2.10.4 France RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.2.10.5 France RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
11.2.11 Spain: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.2.11.1 Spain: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.2.11.2 Spain RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
11.2.11.3 Spain RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.2.11.4 Spain RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.2.11.5 Spain RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
11.2.12 Italy: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.2.12.1 Italy: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.2.12.2 Italy RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
11.2.12.3 Italy RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.2.12.4 Italy RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.2.12.5 Italy RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
11.3 Asia Pacific: RNAi Therapeutics Market
11.3.1 Overview
11.3.2 Asia Pacific: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.3.3 Asia Pacific: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
11.3.4 Asia Pacific: RNAi Therapeutics Market, by Application, 2018-2027 (USD Million)
11.3.5 Asia Pacific: RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.3.6 Asia Pacific: RNAi Therapeutics Market, by End User, 2018-2027 (USD Million)
11.3.7 Asia Pacific: RNAi Therapeutics Market, by Country, 2018 & 2027 (%)
11.3.8 China: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.3.8.1 China: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.3.8.2 China: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
11.3.8.3 China: RNAi Therapeutics Market, by Application, 2018-2027 (USD Million)
11.3.8.4 China RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.3.8.5 China RNAi Therapeutics Market, by End User, 2018-2027 (USD Million)
11.3.9 Japan: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.3.9.1 Japan: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.3.9.2 Japan: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
11.3.9.3 Japan: RNAi Therapeutics Market, by Application, 2018-2027 (USD Million)
11.3.9.4 Japan RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.3.9.5 Japan RNAi Therapeutics Market, by End User, 2018-2027 (USD Million)
11.3.10 India: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.3.10.1 India: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.3.10.2 India: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
11.3.10.3 India: RNAi Therapeutics Market, by Application, 2018-2027 (USD Million)
11.3.10.4 India RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.3.10.5 India RNAi Therapeutics Market, by End User, 2018-2027 (USD Million)
11.3.11 South Korea: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.3.11.1 South Korea: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.3.11.2 South Korea: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
11.3.11.3 South Korea: RNAi Therapeutics Market, by Application, 2018-2027 (USD Million)
11.3.11.4 South Korea RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.3.11.5 South Korea RNAi Therapeutics Market, by End User, 2018-2027 (USD Million)
11.3.12 Australia: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.3.12.1 Australia: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.3.12.2 Australia: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
11.3.12.3 Australia: RNAi Therapeutics Market, by Application, 2018-2027 (USD Million)
11.3.12.4 Australia RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.3.12.5 Australia RNAi Therapeutics Market, by End User, 2018-2027 (USD Million)
11.4 Middle East & Africa: RNAi Therapeutics Market
11.4.1 Overview
11.4.2 Middle East & Africa: RNAi Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
11.4.3 Middle East & Africa: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
11.4.4 Middle East & Africa RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.4.5 Middle East & Africa: RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.4.6 Middle East & Africa RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
11.4.7 Middle East & Africa: RNAi Therapeutics Market, by Country, 2018 & 2027 (%)
11.4.8 Saudi Arabia: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.4.8.1 Saudi Arabia: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.4.8.2 Saudi Arabia: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
11.4.8.3 Saudi Arabia RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.4.8.4 Saudi Arabia: RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.4.8.5 Saudi Arabia RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
11.4.9 UAE: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.4.9.1 UAE: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.4.9.2 UAE: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
11.4.9.3 UAE RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.4.9.4 UAE: RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.4.9.5 UAE RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
11.4.10 South Africa: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.4.10.1 South Africa: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.4.10.2 South Africa: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
11.4.10.3 South Africa RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.4.10.4 South Africa RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.4.10.5 South Africa RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
11.5 South and Central America: RNAi Therapeutics Market
11.5.1 Overview
11.5.2 South and Central America: RNAi Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
11.5.3 South and Central America: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
11.5.4 South and Central America: RNAi Therapeutics Market, by Application, 2018-2027 (USD Million)
11.5.5 South and Central America: RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.5.6 South and Central America: RNAi Therapeutics Market, by End User, 2018-2027 (USD Million)
11.5.7 South and Central America: RNAi Therapeutics Market, by Country, 2018 & 2027 (%)
11.5.8 Brazil: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.5.8.1 Brazil: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.5.8.2 Brazil: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
11.5.8.3 Brazil: RNAi Therapeutics Market, by Application, 2018-2027 (USD Million)
11.5.8.4 Brazil: RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.5.8.5 Brazil: RNAi Therapeutics Market, by End User, 2018-2027 (USD Million)
11.5.9 Argentina: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.5.9.1 Argentina: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.5.9.2 Argentina: RNAi Therapeutics Market, by Molecule Type, 2018-2027 (USD Million)
11.5.9.3 Argentina: RNAi Therapeutics Market, by Application, 2018-2027 (USD Million)
11.5.9.4 Argentina: RNAi Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.5.9.5 Argentina: RNAi Therapeutics Market, by End User, 2018-2027 (USD Million)

12. Impact of COVID-19 Pandemic on Global RNAi Therapeutics Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Rest of World: Impact Assessment of COVID-19 Pandemic

13. RNAi Therapeutics Market -Industry Landscape
13.1 Overview
13.2 Growth Strategies in the RNAi Therapeutics Market, 2015-2020
13.3 Inorganic Growth Strategies
13.3.1 Overview
13.4 Organic Growth Strategies
13.4.1 Overview

14. Company Profiles
14.1 Alnylam Pharmaceuticals, Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Benitec Biopharma
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Sanofi
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 GlaxoSmithKline plc.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Olix Pharmaceuticals, Inc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Arrowhead Pharmaceuticals, Inc
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Quark
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Rexahn Pharmaceuticals, Inc
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Silence Therapeutics
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Arbutus Biopharma
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms



List of Figures


Figure 1. RNAi Therapeutics Market Segmentation
Figure 2. RNAi Therapeutics Market Segmentation, By Region
Figure 3. RNAi Therapeutics Market Overview
Figure 4. Small Interfering RNAs (siRNA) Molecule Type Segment Held Largest Share of RNAi Therapeutics Market
Figure 5. APAC to Show Significant Growth During Forecast Period
Figure 6. RNAi Therapeutics Market, by Geography (US$ Million)
Figure 7. Global RNAi Therapeutics Market - Leading Country Markets (US$ Million)
Figure 8. Global RNAi Therapeutics Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa (MEA) PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. RNAi Therapeutics Market Impact Analysis of Driver and Restraints
Figure 15. Global RNAi Therapeutics Market - Revenue Forecast and Analysis - 2019- 2027
Figure 16. Global RNAi Therapeutics Market - By Geography Forecast and Analysis - 2019- 2027
Figure 17. Market Positioning of Key Players in Global RNAi Therapeutics Market
Figure 18. RNAi Therapeutics Market Share, Molecule Type, 2019 and 2027 (%)
Figure 19. Small Interfering RNAs (siRNA): RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
Figure 20. MicroRNA (miRNA) Market: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
Figure 21. RNAi Therapeutics Market Share, Application, 2019 and 2027 (%)
Figure 22. Genetic Disorders: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
Figure 23. Oncology: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
Figure 24. Neurodegenerative Disorders: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
Figure 25. Cardiovascular Disorders: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
Figure 26. Respiratory Disorders: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
Figure 27. Infectious Disease: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
Figure 28. Renal Diseases: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
Figure 29. Other Disorders: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
Figure 30. RNAi Therapeutics Market Share, Route of Administration, 2019 and 2027 (%)
Figure 31. Intradermal Injections: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
Figure 32. Pulmonary Delivery: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
Figure 33. Intravenous Injections: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
Figure 34. Intraperitoneal Injections: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
Figure 35. Others: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
Figure 36. RNAi Therapeutics Market Share, End User, 2019 and 2027 (%)
Figure 37. Diagnostic Laboratories: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
Figure 38. Research and Academic Laboratories: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
Figure 39. Hospitals: RNAi Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
Figure 40. North America: RNAi Therapeutics Market, by Key Country - Revenue (2019) (USD Million)
Figure 41. North America RNAi Therapeutics Market Revenue and Forecast to 2027 (USD Million)
Figure 42. North America: RNAi Therapeutics Market, by Country, 2019 & 2027 (%)
Figure 43. US: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 44. Canada: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 45. Mexico: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 46. Europe: RNAi Therapeutics Market, by Key Country - Revenue (2019) (USD Million)
Figure 47. Europe RNAi Therapeutics Market Revenue and Forecast to 2027 (USD Million)
Figure 48. Europe: RNAi Therapeutics Market, by Country, 2019 & 2027 (%)
Figure 49. Germany: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 50. UK: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 51. France: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 52. Spain: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 53. Italy: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 54. Asia Pacific: RNAi Therapeutics Market, by Key Country - Revenue (2019) (USD Million)
Figure 55. Asia Pacific RNAi Therapeutics Market Revenue and Forecast to 2027 (USD Million)
Figure 56. China: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 57. Japan: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 58. India: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 59. South Korea: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 60. Australia: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 61. Middle East & Africa: RNAi Therapeutics Market, by Key Country - Revenue (2019) (USD Million)
Figure 62. Middle East & Africa RNAi Therapeutics Market Revenue and Forecast to 2027 (USD Million)
Figure 63. Middle East & Africa: RNAi Therapeutics Market, by Country, 2018 & 2027 (%)
Figure 64. Saudi Arabia: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 65. UAE: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 66. South Africa: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 67. South and Central America: RNAi Therapeutics Market, by Key Country - Revenue (2019) (USD Million)
Figure 68. South and Central America RNAi Therapeutics Market Revenue and Forecast to 2027 (USD Million)
Figure 69. South and Central America: RNAi Therapeutics Market, by Country, 2018 & 2027 (%)
Figure 70. Brazil: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 71. Argentina: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 72. Impact of COVID-19 Pandemic in North American Country Markets
Figure 73. Impact of COVID-19 Pandemic in Europe Country Markets
Figure 74. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
Figure 75. Impact of COVID-19 Pandemic in Rest of World Country Markets
Figure 76. Growth Strategies in the RNAi Therapeutics Market, 2015-2020


List of Tables


Table 1. North America RNAi Therapeutics Market, by Molecule Type- Revenue and Forecast to 2027 (USD Million)
Table 2. North America RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 3. North America RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 4. North America RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 5. US RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
Table 6. US RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 7. US RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 8. US RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 9. Canada RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
Table 10. Canada RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 11. Canada RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 12. Canada RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 13. Mexico RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
Table 14. Mexico RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 15. Mexico RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 16. Mexico RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 17. Europe RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
Table 18. Europe RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 19. Europe RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 20. Europe RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 21. Germany RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
Table 22. Germany RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 23. Germany RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 24. Germany RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 25. United Kingdom RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
Table 26. United Kingdom RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 27. UK: RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million).
Table 28. UK: RNAi Therapeutics Market, End User - Revenue and Forecast to 2027 (USD Million)
Table 29. France RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
Table 30. France RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 31. France RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 32. France RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 33. Spain RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
Table 34. Spain RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 35. Spain RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 36. Spain RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 37. Italy RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
Table 38. Italy RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 39. Italy RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 40. Italy RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 41. Asia Pacific RNAi Therapeutics Market, by Molecule Type- Revenue and Forecast to 2027 (USD Million)
Table 42. Asia Pacific RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 43. Asia Pacific RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 44. Asia Pacific RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 45. China RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
Table 46. China RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 47. China RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 48. China RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 49. Japan RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
Table 50. Japan RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 51. Japan RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 52. Japan RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 53. India RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
Table 54. India RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 55. India RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 56. India RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 57. South Korea RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
Table 58. South Korea RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 59. South Korea RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 60. South Korea RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 61. Incidence, Mortality and Prevalence by cancer site, Australia, 2018
Table 62. Australia RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
Table 63. Australia RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 64. Australia RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 65. Australia RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 66. Middle East & Africa RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
Table 67. Middle East & Africa RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 68. Middle East & Africa RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 69. Middle East & Africa RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 70. Saudi Arabia RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
Table 71. Saudi Arabia RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 72. Saudi Arabia RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 73. Saudi Arabia RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 74. UAE RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
Table 75. UAE RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 76. UAE RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 77. UAE RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 78. South Africa RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
Table 79. South Africa RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 80. South Africa RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 81. South Africa RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 82. South and Central America RNAi Therapeutics Market, by Molecule Type- Revenue and Forecast to 2027 (USD Million)
Table 83. South and Central America RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 84. South and Central America RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 85. South and Central America RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 86. Brazil RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
Table 87. Brazil RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 88. Brazil RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 89. Brazil RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 90. Argentina RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
Table 91. Argentina RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 92. Argentina RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 93. Argentina RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 94. Recent Inorganic Growth Strategies in the RNAi therapeutics market
Table 95. Recent Organic Growth Strategies in the RNAi therapeutics market
Table 96. Glossary of Terms, RNAi Therapeutics Market